An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia

Journal of Lipid Research

Volumn 52, Issue 9, 2011, Pages 1605-1616

  Fan, Jianjia ^a   Stukas, Sophie ^a   Wong, Charmaine ^a   Chan, Jennifer ^a   May, Sharon ^a   DeValle, Nicole ^b   Hirsch Reinshagen, Veronica ^a   Wilkinson, Anna ^a   Oda, Michael N ^b   Wellington, Cheryl L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

ApoE; Lipoprotein; Recycling

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN RECEPTOR; RECEPTOR ASSOCIATED PROTEIN; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GLIA; LIPID METABOLISM; LIPOPROTEIN SECRETION; LIPOPROTEIN SYNTHESIS; MOUSE; NEWBORN; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS REGULATION; WILD TYPE;

ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN; CELLS, CULTURED; CHOLESTEROL; HUMANS; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; NEUROGLIA; PARTICLE SIZE; RECEPTORS, LDL;

EID: 80051818777     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M014365     Document Type: Article

References (85)

1. Lund-Katz, S, and M C Phillips. 2010. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell. Biochem. 51: 183-227.
2. Brooks-Wilson, A., M. Marcil, S M Clee, L. Zhang, K. Roomp, M. Van Dam, L. Yu, C. Brewer, J A Collins, H O F Molhuizen, et al. 1999. Mutations in ABC1 in Tangier disease and familial highdensity lipoprotein deficiency. Nat. Genet. 22: 336-345. (Pubitemid 29369523)
3. Rust, S., M. Rosier, H. Funke, Z. Amoura, J-C Piette, J-F Deleuze, H B Brewer, Jr., N. Duverger, P. Denèfle, and G. Assmann. 1999. Tangier disease is caused by mutations in the gene encoding ATPbinding cassette transporter 1. Nat. Genet. 22: 352-355. (Pubitemid 29369525)
4. Bodzioch, M., E. Orsó, J. Klucken, T. Langmann, A. Böttcher, W. Diederich, W. Drobnik, S. Barlage, C. Büchler, M. Porsch- Özcürümez, et al. 1999. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22: 347-351. (Pubitemid 29369524)
5. Hirsch-Reinshagen, V., S. Zhou, B L Burgess, L. Bernier, S A McIsaac, J Y Chan, G H Tansley, J S Cohn, M R Hayden, and C L Wellington. 2004. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J. Biol. Chem. 279: 41197-41207. (Pubitemid 39287722)
6. Wahrle, S E, H. Jiang, M. Parsadanian, J. Legleiter, X. Han, J D Fryer, T. Kowalewski, and D M Holtzman. 2004. ABCA1 is required for normal CNS apoE levels and for lipidation of astrocyte-secreted apoE. J. Biol. Chem. 279: 40987-40993. (Pubitemid 39287699)
7. Fredrickson, D S, P H Altrocchi, L V Avioli, D W S Goodman, and H C Goodman. 1961. Tangier disease: Combined clinical staff conference at the National Institutes of Health. Ann. Intern. Med. 55: 1016-1031.
8. Dietschy, J M, and S D Turley. 2001. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12: 105-112. (Pubitemid 32242918)
9. Fan, J., J. Donkin, and C L Wellington. 2009. Greasing the wheels of Aβ clearance in Alzheimer's disease: The role of lipids and apolipoprotein E. Biofactors. 35: 239-248.
10. Chattopadhyay, A, and Y D Paila. 2007. Lipid-protein interaction, regulation and dysfuntion of brain cholesterol. Biochem. Biophys. Res. Commun. 354: 627-633. (Pubitemid 46186247)
11. Vanier, M T 2010. Neimann-Pick disease type C. Orphanet J. Rare Dis. 5: 16.
12. Ladu, M J, C. Reardon, L. Van Eldik, A M Fagan, G. Bu, D. Holtzmann, and G S Getz. 2000. Lipoproteins in the central nervous system. Ann. N. Y. Acad. Sci. 903: 167-175. (Pubitemid 30251555)
13. Pitas, R E, J K Boyles, S H Lee, D. Hui, and K H Weisgraber. 1987. Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262: 14352-14360.
14. Saito, K., M. Seishima, M P Heyes, H. Song, S. Fujigaki, S. Maeda, J H Vickers, and A. Noma. 1997. Marked increases in concentrations of apolipoproteins in the cerebrospinal fluid of poliovirus-infected macaques: Relations between apolipoprotein concentrations and severity of brain injury. Biochem. J. 321: 145-149. (Pubitemid 27032581)
15. Song, H., K. Saito, M. Seishima, A. Noma, K. Urakami, and K. Nakashima. 1997. Cerebrospinal fluid apoE and apoA-I concentrations in early- and late-onset Alzheimer's disease. Neurosci. Lett. 231: 175-178. (Pubitemid 27381942)
16. Demeester, N., G. Castro, C. Desrumaux, C. De Geitere, J C Fruchart, P. Santens, E. Mulleners, S. Engelborghs, P P De Deyn, J. Vandekerckhove, et al. 2000. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin: Cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J. Lipid Res. 41: 963-974. (Pubitemid 30434328)
17. Koch, S., N. Donarski, K. Goetze, M. Kreckel, H J Sturernburg, C. Buhmann, and U. Beisiegel. 2001. Characterization of four lipoprotein classes in human cerebrospinal fluid. J. Lipid Res. 42: 1143-1151. (Pubitemid 32645797)
18. Linton, M F, R. Gish, S T Hubl, E. Butler, C. Esquivel, W I Bry, J K Boyles, M R Wardell, and S G Young. 1991. Phenotypes of apoliprotein B and apolipoprotein E after liver transplantation. J. Clin. Invest. 88: 270-281.
19. Ladu, M J, S M Gilligan, J R Lukens, V G Cabana, C A Reardon, L J Van Eldik, and D A Holtzman. 1998. Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70: 2070-2081.
20. Lee, C Y, and G E Landreth. 2010. The role of microglia in amyloid clearance from the AD brain. J. Neural Transm. 117: 949-960.
21. Mahley, R W, and S C Jr.Rall. 2000. Apolipoprotein E: Far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1: 507-537.
22. Bertram, L., C M Lill, and R. Tanzi. 2010. The genetics of Alzheimer disease: Back to the future. Neuron. 68: 270-281.
23. Corder, E H, A M Saunders, W J Strittmatter, D E Schmechel, P C Gaskell, G W Small, A D Roses, J L Haines, and M A Pericak-Vance. 1993. Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease in late onset families. Science. 261: 921-923. (Pubitemid 23275809)
24. Corder, E H, A M Saunders, N J Risch, W J Strittmatter, D E Schmechel, P C Gaskell, J B Rimmler, P A Locke, P M Conneally, K E Schmader, et al. 1994. Protective effect of apolipoprotein E type 2 for late onset Alzheimer disease. Nat. Genet. 7: 180-184. (Pubitemid 24174658)
25. Hirsch-Reinshagen, V., L F Maia, B L Burgess, J F Blain, K E Naus, S A McIsaac, P F Parkinson, J Y Chan, G H Tansley, M R Hayden, et al. 2005. The absence of ABCA1 decreases soluble apoE levels but does not diminish amyloid deposition in two murine models of Alzheimer's disease. J. Biol. Chem. 280: 43243-43256. (Pubitemid 43049291)
26. Wahrle, S E, H. Jiang, M. Parsadanian, R E Hartman, K R Bales, S M Paul, and D M Holtzman. 2005. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease. J. Biol. Chem. 280: 43236-43242. (Pubitemid 43049290)
27. Koldamova, R P, I M Lefterov, M. Staufenbiel, D. Wolfe, S. Huang, J C Glorioso, M. Walter, M G Roth, and J S Lazo. 2005. The liver X receptor ligand TO901317 decreases amyloid β production in vitro and in a mouse model of Alzheimer's disease. J. Biol. Chem. 280: 4079-4088. (Pubitemid 40288571)
28. Wahrle, S E, H. Jiang, M. Parsadanian, J. Kim, A. Li, A. Knoten, S. Jain, V. Hirsch-Reinshagen, C L Wellington, K R Bales, et al. 2008. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J. Clin. Invest. 118: 671-682. (Pubitemid 351206556)
29. Jiang, Q., C Y Lee, S. Mandrekar, B. Wilkinson, P. Cramer, N. Zelcer, K. Mann, B. Lamb, T M Willson, J L Collins, et al. 2008. ApoE promotes the proteolytic degradation of Abeta. Neuron. 58: 681-693. (Pubitemid 351778466)
30. Verghese, P B, J M Castellano, and D M Holtzman. 2011. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 10: 241-252.
31. Rothblat, G H, and M C Phillips. 2010. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr. Opin. Lipidol. 21: 229-238.
32. Cavigiolio, G., B. Shao, E G Geier, G. Ren, J W Heinecke, and M N Oda. 2008. The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses. Biochemistry. 47: 4770-4779. (Pubitemid 351555498)
33. Timmins, J M, J Y Lee, E. Boudyguina, K D Kluckman, L R Brunham, A. Mulya, A K Gebre, J M Coutinho, P L Colvin, T L Smith, et al. 2005. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteimemia and kidney hypercatabolism of apoA-I. J. Clin. Invest. 115: 1333-1342. (Pubitemid 40629053)
34. Brunham, L R, J K Kruit, J. Iqbal, C. Fievet, J M Timmins, T D Pape, B A Coburn, N. Bissada, B. Staels, A K Groen, et al. 2006. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest. 116: 1052-1062.
35. Asztalos, B F, E J Schaefer, K V Horvath, S. Yamashita, M. Miller, G. Franceschini, and L. Calabresi. 2007. Role of LCAT in HDL remodeling: Investigation of LCAT deficiency states. J. Lipid Res. 48: 592-599. (Pubitemid 46397462)
36. Acton, S., A. Rigotti, K T Landschulz, S. Xu, H H Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
37. Fagan, A M, D M Holtzman, G. Munson, T. Mathur, D. Schnieder, L K Chang, G S Getz, C A Reardon, J. Lukens, J A Shah, et al. 1999. Unique lipoproteins secreted by primary astrocytes from wild type, wild type, apoE (-/-), and human apoE transgenic Mice. J. Biol. Chem. 274: 30001-30004.
38. DeMattos, R B, R P Brendza, J E Heuser, M. Kierson, J R Cirrito, J. Fryer, P M Sullivan, A M Fagan, X. Han, and D A Holtzman. 2001. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice. Neurochem. Int. 39: 415-425. (Pubitemid 32907406)
39. Hirsch-Reinshagen, V, and C L Wellington. 2007. Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease. Curr. Opin. Lipidol. 18: 325-332. (Pubitemid 46743058)
40. McNeish, J., R J Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K L Hoppe, M L Roach, L J Royer, J. De Wet, et al. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA. 97: 4245-4250. (Pubitemid 30226118)
41. Ryan, R O, T M Forte, and M N Oda. 2003. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr. Purif. 27: 98-103. (Pubitemid 37096475)
42. Rensen, P C N, M C Jong, L C Van Vark, H. Van der Boom, W L Hendricks, T J C Van Berkel, E A L Biessen, and L M Havekes. 2000. Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. J. Biol. Chem. 275: 8564-8571. (Pubitemid 30180205)
43. Fazio, S., M F Linton, A H Hasty, and L L Swift. 1999. Recycling of apolipoprotein E in mouse liver. J. Biol. Chem. 274: 8247-8253.
44. Fazio, S., M F Linton, and L L Swift. 2000. The cell biology and physiologic relevance of ApoE recycling. Trends Cardiovasc. Med. 10: 23-30. (Pubitemid 32012678)
45. Swift, L L, M H Farkas, A S Major, K. Valyi-Nagy, M F Linton, and S. Fazio. 2001. A recycling pathway for resecretion of internalized apolipoprotien E in liver cells. J. Biol. Chem. 276: 22965-22970.
46. Ladu, M J, J A Shah, C A Reardon, G S Getz, G. Bu, J. Hu, L. Guo, and L J Van Eldik. 2000. Apolipoprotein E receptors mediate the effects of β-amyloid on astrocyte cultures. J. Biol. Chem. 275: 33974-33980.
47. Braun, N A, P J Mohler, K H Weisgraber, A H Hasty, M F Linton, P G Yancey, Y R Su, S. Fazio, and L L Swift. 2006. Intracellular trafficing of recycling apolipoprotein E in Chinese hamster ovary cells. J. Lipid Res. 47: 1176-1186. (Pubitemid 43830709)
48. Heeren, J., T. Grewal, A. Laatsch, D. Rottke, F. Rinninger, C. Enrich, and U. Beisiegel. 2003. Recycling of apolipoprotein E is associated with cholesterol efflux and high density lipoprotein internalization. J. Biol. Chem. 278: 14370-14378. (Pubitemid 36799988)
49. Heeren, J., U. Beisiegel, and T. Grewal. 2006. Apolipoprotein E recycling implications for dyslipidemia and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26: 442-448.
50. Hasty, A H, M R Plummer, K H Weisgraber, M F Linton, R. Fazio, and L L Swift. 2005. The recycling of apolipoprotein E in macrophages: Influence of HDL and apolipoprotein A-I. J. Lipid Res. 46: 1433-1439. (Pubitemid 43109807)
51. Farkas, M H, L L Swift, A H Hasty, M F Linton, and S. Fazio. 2003. The recycling of apolipoprotein E in primary cultures of mouse hepatocytes. J. Biol. Chem. 278: 9412-9417.
52. Bencharif, K., L. Hoareau, R K Murumalla, E. Tamus, F. Tallet, R G Clerc, C. Gardes, M. Cesari, and R. Roche. 2010. Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes. Lipids Health Dis. 9: 75-84.
53. Dory, L. 1991. Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages. J. Lipid Res. 32: 783-792.
54. Dory, L. 1989. Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: Effect of cholesterol efflux. J. Lipid Res. 30: 809-816. (Pubitemid 19167303)
55. Rellin, L., J. Heeren, and U. Beisiegel. 2008. Recycling of apolipoprotein E is not associated with cholesterol efflux in neuronal cells. Biochim. Biophys. Acta. 1781: 232-238.
56. Kockx, M., K-A Rye, K. Gaus, C M Quinn, J. Wright, T. Sloane, D. Sviridov, Y. Fu, D. Sullivan, J R Burnett, et al. 2004. Apolipoprotein A-I-stimulated apolipoprotein E secretion from human macrophages is independent of cholesterol efflux. J. Biol. Chem. 279: 25966-25977. (Pubitemid 38798738)
57. Catte, A., J C Patterson, M K Jones, W G Jerome, D. Bashtovyy, Z. Su, F. Gu, J. Chen, M P Aliste, S C Harvey, et al. 2006. Novel changes in discoidal high density lipoprotein morphology: A molecular dynamics study. Biophys. J. 90: 4345-4360. (Pubitemid 43830883)
58. Zhang, L., J. Song, G. Cavigiolio, B Y Ishida, S. Zhang, J P Kane, K H Weisgraber, M N Oda, K A Rye, H J Pownall, et al. 2011. Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy. J. Lipid Res. 52: 175-178.
59. Ladu, M J, W B Stine, M. Narita, G S Getz, C A Reardon, and G. Bu. 2006. Self-assembly of HEK cell-secreted apoE particles resembes apoE enrichment of lipoproteins as a ligand for the LDL receptor-related protein. Biochemistry. 45: 381-390. (Pubitemid 43100405)
60. Rensen, P C, N. Herjgers, M H Netscher, S C Meskers, M. Van Eck, and T J Van Berkel. 1997. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J. Lipid Res. 38: 1070-1084. (Pubitemid 27281803)
61. Farkas, M H, K H Weisgraber, V L Shepherd, M F Linton, S. Fazio, and L L Swift. 2004. The recycling of apolipoprotein E and its amino-terminal 22 kDa fragment: Evidence for multiple redundant pathways. J. Lipid Res. 45: 1546-1554. (Pubitemid 39006983)
62. Heeren, J., T. Grewal, S. Jackle, and U. Beisiegel. 2001. Recycling of apolipoprotein E and lipoprotein lipase through endosomeal compartments in vivo. J. Biol. Chem. 276: 42333-42338.
63. Takahashi, Y, and J D Smith. 1999. Cholesterol efflux to apolipoprotein A1 involves endocytosis and resecretion in a calciumdependent pathway. Proc. Natl. Acad. Sci. USA. 96: 11358-11363. (Pubitemid 29487385)
64. Neufeld, E B, J A Stonick, S J Demosky, C L Knapper, C A Combs, A. Cooney, M. Comly, N. Dwyer, J. Blanchette-Mackie, A T Remaley, et al. 2004. The ABCA1 transporter modulates late endocytic trafficking. J. Biol. Chem. 279: 15571-15578.
65. Denis, M., Y D Landry, and X. Zha. 2008. ATP-binding cassett A1-mediated lipidation of apoA-I occurs at the plasma membrane and not in the endocytic compartment. J. Biol. Chem. 283: 16178-16186.
66. Lefterov, I., N F Fitz, A A Cronican, A. Fogg, P. Lefterov, R. Kodali, R. Wetze, and R. Koldamova. 2010. Apolipoprotein A-I deficiency increases cerebral amyloid angiopathy and cognitive deficits in APP/PS1E9 mice. J. Biol. Chem. 285: 36945-36957.
67. Lewis, T L, D. Cao, H. Lu, R A Mans, Y R Su, L. Jungbauer, M F Linton, S. Fazio, M J Ladu, and L. Li. 2010. Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer's disease. J. Biol. Chem. 285: 36958-36968.
68. Fagan, A M, E. Christopher, J W Taylor, M. Parsadanian, M. Spinner, M. Watson, J D Fryer, S. Wahrle, K R Bales, S M Paul, et al. 2004. ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis. Am. J. Pathol. 165: 1413-1422. (Pubitemid 39297745)
69. Heeren, J., T. Grewal, A. Laatsch, N. Becker, F. Rinninger, K-A Rye, and U. Beisiegel. 2004. Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation. J. Biol. Chem. 279: 55483-55492. (Pubitemid 40066549)
70. Zhong, N, and K H Weisgraber. 2009. Understanding the association of apolipoprotein E4 with Alzheimer disease: Clues from its structure. J. Biol. Chem. 284: 6027-6031.
71. Zhong, N., G. Ramaswamy, and K H Weisgraber. 2009. Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function. J. Biol. Chem. 284: 27273-27280.
72. Hatters, D M, M S Budamagunta, J C Voss, and K H Weisgraber. 2005. Modulation of apolipoprotein E structure by domain interaction. J. Biol. Chem. 280: 34288-34295.
73. Morrow, J A, D M Hatters, B. Lu, P. Hochti, K A Oberg, B. Rupp, and K H Weisgraber. 2002. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. J. Biol. Chem. 277: 50380-50385. (Pubitemid 36042188)
74. Dong, L-M, C. Wilson, M R Wardell, T. Simmons, R W Mahley, K H Weisgraber, and D A Agard. 1994. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269: 22358-22365.
75. Chen, Y., M S Durakoglugil, X. Xian, and J. Herz. 2010. ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc. Natl. Acad. Sci. USA. 107: 12011-12016.
76. Riddell, D R, H. Zhou, K. Atchison, H K Warwick, J. Jefferson, L. Xu, S. Aschmies, Y. Kirksey, Y. Hu, E. Wagner, et al. 2008. Impact of apolipoprotein E (apoE) polymorphism on brain apoE levels. J. Neurosci. 28: 11445-11453.
77. Bertrand, P., J. Poirier, T. Oda, C E Finch, and G M Pasinetti. 1995. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer dsiease. Brain Res. Mol. Brain Res. 33: 174-178.
78. Beffert, U., J S Cohn, C. Petit-Turcotte, M. Tremblay, N. Aumont, C. Ramassamy, J. Davignon, and J. Poirier. 1999. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent. Brain Res. 843: 87-94. (Pubitemid 29488698)
79. Poirier, J. 2005. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol. Aging. 26: 355-361. (Pubitemid 40082719)
80. Glockner, F., V. Meske, and T G Ohm. 2002. Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease. Neuroscience.114: 1103-1114.
81. Ramaswamy, G., Q. Xu, Y. Huang, and K H Weisgraber. 2005. Effect of domain interaction on apolipoprotein E levels in mouse brain. J. Neurosci. 25: 10658-10663. (Pubitemid 41681913)
82. Fryer, J D, K. Simmons, M. Parsadanian, K R Bales, S M Paul, P M Sullivan, and D M Holtzman. 2005. Human apolipoprotein E4 alters the amyloid-beta 40: 42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J. Neurosci. 25: 2803-2810. (Pubitemid 40389238)
83. Sullivan, P M, B E Mace, N. Maeda, and D E Schmechel. 2004. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience. 124: 725-733. (Pubitemid 38328762)
84. Fukumoto, H., M. Tennis, J J Locascio, B T Hyman, J H Growdon, and M C Irizarry. 2003. Age but not diagnosis is the main predictor of plasma amyloid β-protein levels. Arch. Neurol. 60: 958-964. (Pubitemid 36858355)
85. Koldamova, R., M. Staufenbiel, and I. Lefterov. 2005. Lack of ABCA1 considerably decreases brain apoE level and increases amyloid deposition in APP23 mice. J. Biol. Chem. 280: 43224-43235. (Pubitemid 43049289)